Annual Drug Patent Expirations for RHOPRESSA
Rhopressa is a drug marketed by Alcon Labs Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.
Drug patent litigation for RHOPRESSA.
This drug has sixty-four patent family members in fourteen countries.
The generic ingredient in RHOPRESSA is netarsudil mesylate. One supplier is listed for this compound. Additional details are available on the netarsudil mesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
